APO Research
Talk to an analyst

APO RESEARCH · REPORT

5G for Medical

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global 5G for Medical Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry Research5G for Medical Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal 5G for Medical Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal 5G for Medical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 5G for Medical Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal 5G for Medical Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global 5G for Medical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for 5G for Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 5G for Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 5G for Medical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the 5G for Medical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the 5G for Medical market include AT&T, Capsule Technologies, Microsoft, Intel Corporation, Cisco, Accenture, Verizon Communications, Ericsson and Oracle, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global 5G for Medical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 5G for Medical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 5G for Medical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global 5G for Medical market.

5G for Medical Segment by Company

AT&T

Capsule Technologies

Microsoft

Intel Corporation

Cisco

Accenture

Verizon Communications

Ericsson

Oracle

Juniper Networks

Nokia

Samsung Electronics

NEC

Huawei

ZTE

5G for Medical Segment by Type

Patient Monitoring

Remote Diagnosis

Robotic surgery (Procedures)

Others（Remote Medical Learning）

5G for Medical Segment by Application

Hospital

Home Healthcare

Educational Institution

Others

5G for Medical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global 5G for Medical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the 5G for Medical key companies, revenue, market share, and recent developments.

3. To split the 5G for Medical breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions 5G for Medical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify 5G for Medical significant trends, drivers, influence factors in global and regions.

6. To analyze 5G for Medical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 5G for Medical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 5G for Medical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 5G for Medical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 5G for Medical industry.

Chapter 3: Detailed analysis of 5G for Medical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of 5G for Medical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of 5G for Medical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. 5G for Medical Industry Trends Table 2. 5G for Medical Industry Drivers Table 3. 5G for Medical Industry Opportunities and Challenges Table 4. 5G for Medical Industry Restraints Table 5. Global 5G for Medical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global 5G for Medical Revenue Share by Company (2021-2026) Table 7. Global 5G for Medical Company Ranking, (2024-2026) & (US$ Million) Table 8. Global 5G for Medical Key Company Manufacturing Base & Headquarters Table 9. Global 5G for Medical Company, Product Type & Application Table 10. Global 5G for Medical Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global 5G for Medical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Patient Monitoring Table 15. Significant Companies of Remote Diagnosis Table 16. Significant Companies of Robotic surgery (Procedures) Table 17. Significant Companies of Others（Remote Medical Learning） Table 18. Global 5G for Medical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global 5G for Medical Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global 5G for Medical Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global 5G for Medical Sales Value Share by Type (2021-2026) Table 22. Global 5G for Medical Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Home Healthcare Table 25. Significant Companies of Educational Institution Table 26. Significant Companies of Others Table 27. Global 5G for Medical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global 5G for Medical Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global 5G for Medical Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global 5G for Medical Sales Value Share by Application (2021-2026) Table 31. Global 5G for Medical Sales Value Share by Application (2027-2032) Table 32. Global 5G for Medical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global 5G for Medical Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global 5G for Medical Sales Value Share by Region (2021-2026) Table 35. Global 5G for Medical Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global 5G for Medical Sales Value Share by Region (2027-2032) Table 37. Global 5G for Medical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global 5G for Medical Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global 5G for Medical Sales Value Market Share by Country (2021-2026) Table 40. Global 5G for Medical Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global 5G for Medical Sales Value Market Share by Country (2027-2032) Table 42. AT&T Company Information Table 43. AT&T Business Overview Table 44. AT&T 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. AT&T 5G for Medical Product Portfolio Table 46. AT&T Recent Development Table 47. Capsule Technologies Company Information Table 48. Capsule Technologies Business Overview Table 49. Capsule Technologies 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Capsule Technologies 5G for Medical Product Portfolio Table 51. Capsule Technologies Recent Development Table 52. Microsoft Company Information Table 53. Microsoft Business Overview Table 54. Microsoft 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Microsoft 5G for Medical Product Portfolio Table 56. Microsoft Recent Development Table 57. Intel Corporation Company Information Table 58. Intel Corporation Business Overview Table 59. Intel Corporation 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Intel Corporation 5G for Medical Product Portfolio Table 61. Intel Corporation Recent Development Table 62. Cisco Company Information Table 63. Cisco Business Overview Table 64. Cisco 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Cisco 5G for Medical Product Portfolio Table 66. Cisco Recent Development Table 67. Accenture Company Information Table 68. Accenture Business Overview Table 69. Accenture 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Accenture 5G for Medical Product Portfolio Table 71. Accenture Recent Development Table 72. Verizon Communications Company Information Table 73. Verizon Communications Business Overview Table 74. Verizon Communications 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Verizon Communications 5G for Medical Product Portfolio Table 76. Verizon Communications Recent Development Table 77. Ericsson Company Information Table 78. Ericsson Business Overview Table 79. Ericsson 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Ericsson 5G for Medical Product Portfolio Table 81. Ericsson Recent Development Table 82. Oracle Company Information Table 83. Oracle Business Overview Table 84. Oracle 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Oracle 5G for Medical Product Portfolio Table 86. Oracle Recent Development Table 87. Juniper Networks Company Information Table 88. Juniper Networks Business Overview Table 89. Juniper Networks 5G for Medical Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Juniper Networks 5G for Medical Product Portfolio Table 91. Juniper Networks Recent Development Table 92. Nokia Company Information Table 93. Nokia Business Overview Table 94. Nokia 5G for Medical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Nokia 5G for Medical Product Portfolio Table 96. Nokia Recent Development Table 97. Samsung Electronics Company Information Table 98. Samsung Electronics Business Overview Table 99. Samsung Electronics 5G for Medical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Samsung Electronics 5G for Medical Product Portfolio Table 101. Samsung Electronics Recent Development Table 102. NEC Company Information Table 103. NEC Business Overview Table 104. NEC 5G for Medical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. NEC 5G for Medical Product Portfolio Table 106. NEC Recent Development Table 107. Huawei Company Information Table 108. Huawei Business Overview Table 109. Huawei 5G for Medical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Huawei 5G for Medical Product Portfolio Table 111. Huawei Recent Development Table 112. ZTE Company Information Table 113. ZTE Business Overview Table 114. ZTE 5G for Medical Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. ZTE 5G for Medical Product Portfolio Table 116. ZTE Recent Development Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. 5G for Medical Product Image Figure 2. Global 5G for Medical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 5G for Medical Market Size (2021-2032) & (US$ Million) Figure 4. Global 5G for Medical Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Patient Monitoring Image Figure 8. Remote Diagnosis Image Figure 9. Robotic surgery (Procedures) Image Figure 10. Others（Remote Medical Learning） Image Figure 11. Global 5G for Medical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global 5G for Medical Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global 5G for Medical Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Home Healthcare Image Figure 16. Educational Institution Image Figure 17. Others Image Figure 18. Global 5G for Medical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global 5G for Medical Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global 5G for Medical Sales Value Share by Application (2021-2032) Figure 21. Global 5G for Medical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global 5G for Medical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America 5G for Medical Sales Value (2021-2032) & (US$ Million) Figure 24. North America 5G for Medical Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe 5G for Medical Sales Value (2021-2032) & (US$ Million) Figure 26. Europe 5G for Medical Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific 5G for Medical Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific 5G for Medical Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America 5G for Medical Sales Value (2021-2032) & (US$ Million) Figure 30. South America 5G for Medical Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa 5G for Medical Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa 5G for Medical Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt 5G for Medical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt 5G for Medical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt 5G for Medical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Patient Monitoring
  • Remote Diagnosis
  • Robotic surgery (Procedures)
  • Others（Remote Medical Learning）
Applications
  • Hospital
  • Home Healthcare
  • Educational Institution
  • Others
Companies covered
  • AT&T
  • Capsule Technologies
  • Microsoft
  • Intel Corporation
  • Cisco
  • Accenture
  • Verizon Communications
  • Ericsson
  • Oracle
  • Juniper Networks
  • Nokia
  • Samsung Electronics
  • NEC
  • Huawei
  • ZTE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global 5G for Medical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global 5G for Medical Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 5G for Medical Market Dynamics
  1. 2.1 5G for Medical Industry Trends
  2. 2.2 5G for Medical Industry Drivers
  3. 2.3 5G for Medical Industry Opportunities and Challenges
  4. 2.4 5G for Medical Industry Restraints
3 5G for Medical Market by Company
  1. 3.1 Global 5G for Medical Company Revenue Ranking in 2025
  2. 3.2 Global 5G for Medical Revenue by Company (2021-2026)
  3. 3.3 Global 5G for Medical Company Ranking (2024-2026)
  4. 3.4 Global 5G for Medical Company Manufacturing Base and Headquarters
  5. 3.5 Global 5G for Medical Company Product Type and Application
  6. 3.6 Global 5G for Medical Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global 5G for Medical Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 5G for Medical Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 5G for Medical Market by Type
  1. 4.1 5G for Medical Type Introduction
  2. 4.1.1 Patient Monitoring
  3. 4.1.2 Remote Diagnosis
  4. 4.1.3 Robotic surgery (Procedures)
  5. 4.1.4 Others（Remote Medical Learning）
  6. 4.2 Global 5G for Medical Sales Value by Type
  7. 4.2.1 Global 5G for Medical Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global 5G for Medical Sales Value by Type (2021-2032)
  9. 4.2.3 Global 5G for Medical Sales Value Share by Type (2021-2032)
5 5G for Medical Market by Application
  1. 5.1 5G for Medical Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Home Healthcare
  4. 5.1.3 Educational Institution
  5. 5.1.4 Others
  6. 5.2 Global 5G for Medical Sales Value by Application
  7. 5.2.1 Global 5G for Medical Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global 5G for Medical Sales Value by Application (2021-2032)
  9. 5.2.3 Global 5G for Medical Sales Value Share by Application (2021-2032)
6 5G for Medical Regional Value Analysis
  1. 6.1 Global 5G for Medical Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 5G for Medical Sales Value by Region (2021-2032)
  3. 6.2.1 Global 5G for Medical Sales Value by Region: 2021-2026
  4. 6.2.2 Global 5G for Medical Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America 5G for Medical Sales Value (2021-2032)
  7. 6.3.2 North America 5G for Medical Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe 5G for Medical Sales Value (2021-2032)
  10. 6.4.2 Europe 5G for Medical Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific 5G for Medical Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific 5G for Medical Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America 5G for Medical Sales Value (2021-2032)
  16. 6.6.2 South America 5G for Medical Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa 5G for Medical Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa 5G for Medical Sales Value Share by Country, 2025 VS 2032
7 5G for Medical Country-level Value Analysis
  1. 7.1 Global 5G for Medical Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global 5G for Medical Sales Value by Country (2021-2032)
  3. 7.2.1 Global 5G for Medical Sales Value by Country (2021-2026)
  4. 7.2.2 Global 5G for Medical Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA 5G for Medical Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA 5G for Medical Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA 5G for Medical Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada 5G for Medical Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada 5G for Medical Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada 5G for Medical Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico 5G for Medical Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico 5G for Medical Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico 5G for Medical Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany 5G for Medical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany 5G for Medical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany 5G for Medical Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France 5G for Medical Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France 5G for Medical Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France 5G for Medical Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. 5G for Medical Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. 5G for Medical Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. 5G for Medical Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy 5G for Medical Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy 5G for Medical Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy 5G for Medical Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain 5G for Medical Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain 5G for Medical Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain 5G for Medical Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia 5G for Medical Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia 5G for Medical Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia 5G for Medical Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands 5G for Medical Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands 5G for Medical Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands 5G for Medical Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries 5G for Medical Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries 5G for Medical Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries 5G for Medical Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China 5G for Medical Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China 5G for Medical Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China 5G for Medical Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan 5G for Medical Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan 5G for Medical Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan 5G for Medical Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea 5G for Medical Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea 5G for Medical Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea 5G for Medical Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India 5G for Medical Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India 5G for Medical Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India 5G for Medical Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia 5G for Medical Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia 5G for Medical Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia 5G for Medical Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia 5G for Medical Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia 5G for Medical Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia 5G for Medical Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil 5G for Medical Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil 5G for Medical Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil 5G for Medical Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina 5G for Medical Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina 5G for Medical Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina 5G for Medical Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile 5G for Medical Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile 5G for Medical Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile 5G for Medical Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia 5G for Medical Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia 5G for Medical Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia 5G for Medical Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru 5G for Medical Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru 5G for Medical Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru 5G for Medical Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia 5G for Medical Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia 5G for Medical Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia 5G for Medical Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel 5G for Medical Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel 5G for Medical Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel 5G for Medical Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE 5G for Medical Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE 5G for Medical Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE 5G for Medical Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey 5G for Medical Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey 5G for Medical Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey 5G for Medical Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran 5G for Medical Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran 5G for Medical Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran 5G for Medical Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt 5G for Medical Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt 5G for Medical Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt 5G for Medical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AT&T
  2. 8.1.1 AT&T Company Information
  3. 8.1.2 AT&T Business Overview
  4. 8.1.3 AT&T 5G for Medical Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AT&T 5G for Medical Product Portfolio
  6. 8.1.5 AT&T Recent Developments
  7. 8.2 Capsule Technologies
  8. 8.2.1 Capsule Technologies Company Information
  9. 8.2.2 Capsule Technologies Business Overview
  10. 8.2.3 Capsule Technologies 5G for Medical Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Capsule Technologies 5G for Medical Product Portfolio
  12. 8.2.5 Capsule Technologies Recent Developments
  13. 8.3 Microsoft
  14. 8.3.1 Microsoft Company Information
  15. 8.3.2 Microsoft Business Overview
  16. 8.3.3 Microsoft 5G for Medical Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Microsoft 5G for Medical Product Portfolio
  18. 8.3.5 Microsoft Recent Developments
  19. 8.4 Intel Corporation
  20. 8.4.1 Intel Corporation Company Information
  21. 8.4.2 Intel Corporation Business Overview
  22. 8.4.3 Intel Corporation 5G for Medical Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Intel Corporation 5G for Medical Product Portfolio
  24. 8.4.5 Intel Corporation Recent Developments
  25. 8.5 Cisco
  26. 8.5.1 Cisco Company Information
  27. 8.5.2 Cisco Business Overview
  28. 8.5.3 Cisco 5G for Medical Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cisco 5G for Medical Product Portfolio
  30. 8.5.5 Cisco Recent Developments
  31. 8.6 Accenture
  32. 8.6.1 Accenture Company Information
  33. 8.6.2 Accenture Business Overview
  34. 8.6.3 Accenture 5G for Medical Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Accenture 5G for Medical Product Portfolio
  36. 8.6.5 Accenture Recent Developments
  37. 8.7 Verizon Communications
  38. 8.7.1 Verizon Communications Company Information
  39. 8.7.2 Verizon Communications Business Overview
  40. 8.7.3 Verizon Communications 5G for Medical Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Verizon Communications 5G for Medical Product Portfolio
  42. 8.7.5 Verizon Communications Recent Developments
  43. 8.8 Ericsson
  44. 8.8.1 Ericsson Company Information
  45. 8.8.2 Ericsson Business Overview
  46. 8.8.3 Ericsson 5G for Medical Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ericsson 5G for Medical Product Portfolio
  48. 8.8.5 Ericsson Recent Developments
  49. 8.9 Oracle
  50. 8.9.1 Oracle Company Information
  51. 8.9.2 Oracle Business Overview
  52. 8.9.3 Oracle 5G for Medical Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Oracle 5G for Medical Product Portfolio
  54. 8.9.5 Oracle Recent Developments
  55. 8.10 Juniper Networks
  56. 8.10.1 Juniper Networks Company Information
  57. 8.10.2 Juniper Networks Business Overview
  58. 8.10.3 Juniper Networks 5G for Medical Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Juniper Networks 5G for Medical Product Portfolio
  60. 8.10.5 Juniper Networks Recent Developments
  61. 8.11 Nokia
  62. 8.11.1 Nokia Company Information
  63. 8.11.2 Nokia Business Overview
  64. 8.11.3 Nokia 5G for Medical Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nokia 5G for Medical Product Portfolio
  66. 8.11.5 Nokia Recent Developments
  67. 8.12 Samsung Electronics
  68. 8.12.1 Samsung Electronics Company Information
  69. 8.12.2 Samsung Electronics Business Overview
  70. 8.12.3 Samsung Electronics 5G for Medical Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Samsung Electronics 5G for Medical Product Portfolio
  72. 8.12.5 Samsung Electronics Recent Developments
  73. 8.13 NEC
  74. 8.13.1 NEC Company Information
  75. 8.13.2 NEC Business Overview
  76. 8.13.3 NEC 5G for Medical Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NEC 5G for Medical Product Portfolio
  78. 8.13.5 NEC Recent Developments
  79. 8.14 Huawei
  80. 8.14.1 Huawei Company Information
  81. 8.14.2 Huawei Business Overview
  82. 8.14.3 Huawei 5G for Medical Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Huawei 5G for Medical Product Portfolio
  84. 8.14.5 Huawei Recent Developments
  85. 8.15 ZTE
  86. 8.15.1 ZTE Company Information
  87. 8.15.2 ZTE Business Overview
  88. 8.15.3 ZTE 5G for Medical Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ZTE 5G for Medical Product Portfolio
  90. 8.15.5 ZTE Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst